About the Author

---

Martine Rothblatt is an attorney, medical ethicist and biotech executive. Dr Rothblatt has been principally responsible for two global agreements as well as for the International Bar Association's Human Genome Treaty draft now before the United Nations. She is also the founder and chief executive of United Therapeutics, a US-based firm with an approved medicine for pulmonary hypertension, a frequent cause of lung or heart-lung transplantation.